The AI engine Fit Assessment
BetaIntelligent OMICS leverages machine learning to discover patterns and expand therapeutic options, while also identifying biomarkers for personalized medicine.
Blurb
HQ Location
Founded
Employees
Total funding raised
Last Funding Event
Smart insights
Developer of an automated drug discovery platform designed to identify new drugs and companion diagnostics. The company's platform uses artificial intelligence to model molecular data, discerning the underlying disease pathway for each disease that helps to predict pre-clinical tox effects, saving up pre-clinical development costs and reducing the need for animal trials, enabling pharma and biotech companies to discover novel targets and to accelerate programs through to IND.